Lanthanum carbonate (Prasco Laboratories)
Welcome to the PulseAid listing for the Lanthanum carbonate drug offered from Prasco Laboratories. This Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Prasco Laboratories |
NON-PROPRIETARY NAME: | LANTHANUM CARBONATE |
SUBSTANCE NAME: | LANTHANUM CARBONATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, CHEWABLE |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2017-08-30 |
END MARKETING DATE: | 0000-00-00 |
Lanthanum carbonate HUMAN PRESCRIPTION DRUG Details:
Item Description | Lanthanum carbonate from Prasco Laboratories |
LABELER NAME: | Prasco Laboratories |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/1) |
START MARKETING DATE: | 2017-08-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 66993-422_7f2a2f9a-86e3-4a11-81c8-11a3bf88bbe9 |
PRODUCT NDC: | 66993-422 |
APPLICATION NUMBER: | NDA021468 |
Other LANTHANUM CARBONATE Pharmaceutical Manufacturers / Labelers: